evidencegaps
Primary study · included by 1 review

Evaluation of neoadjuvant chemotherapy combined with PD-1 inhibitors in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma: a comparative study of antitumor activity.

Xu 2023 · Xu Pengfei, Fang Qi, Zhao Zheng, et al. · Cancer immunology, immunotherapy : CII · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Xu 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.